Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:30 pm Purchase | 2026-06-30 | 13G | ERASCA INC ERAS | City Hill, LLC | 36,968,486 10.400% | 3,065,686 (+9.04%) | Filing History |
| 2026-05-15 4:34 pm Purchase | 2026-03-31 | 13G | ERASCA INC ERAS | Venrock Healthcare Capital Partners III, L.P. | 16,382,812 5.300% | 166,596 (+1.03%) | Filing History |
| 2026-05-15 4:25 pm Sale | 2026-03-31 | 13G | ERASCA INC ERAS | Paradigm BioCapital Advisors LP | 10,392,702 3.300% | -4,766,393 (-31.44%) | Filing History |
| 2026-05-15 10:06 am Purchase | 2026-03-31 | 13G | ERASCA INC ERAS | T. Rowe Price Investment Management, Inc. | 21,224,264 6.800% | 5,112,850 (+31.73%) | Filing History |
| 2026-05-15 08:20 am Purchase | 2026-03-31 | 13G | ERASCA INC ERAS | RTW Investments, LP | 16,157,175 5.200% | 16,157,175 (New Position) | Filing History |
| 2026-05-12 6:24 pm Sale | 2026-03-31 | 13G | ERASCA INC ERAS | Montanova Capital, LLC | 3,434,967 1.100% | -11,067,037 (-76.31%) | Filing History |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | ERASCA INC ERAS | T. Rowe Price Investment Management, Inc. | 16,111,414 5.700% | -4,220,747 (-20.76%) | Filing History |
| 2026-01-14 4:30 pm Purchase | 2026-01-07 | 13G | ERASCA INC ERAS | Paradigm BioCapital Advisors LP | 15,159,095 5.300% | 15,159,095 (New Position) | Filing History |
| 2025-11-14 12:59 pm Sale | 2025-09-30 | 13G | ERASCA INC ERAS | Logos Global Management LP | 13,600,000 4.800% | -1,500,000 (-9.93%) | Filing History |
| 2025-08-14 4:56 pm Purchase | 2025-06-30 | 13G | ERASCA INC ERAS | Logos Global Management LP | 15,100,000 5.300% | 15,100,000 (New Position) | Filing History |
| 2025-08-14 1:10 pm Sale | 2025-06-30 | 13G | ERASCA INC ERAS | Frazier Life Sciences Public Fund, L.P. | 15,038,753 5.300% | -7,537,098 (-33.39%) | Filing History |
| 2025-08-14 12:12 pm Purchase | 2025-06-30 | 13G | ERASCA INC ERAS | T. Rowe Price Investment Management, Inc. | 20,332,161 7.200% | 3,501,305 (+20.80%) | Filing History |
| 2025-08-13 8:14 pm Purchase | 2025-06-30 | 13G | ERASCA INC ERAS | Montanova Capital, LLC | 14,502,004 5.100% | 2,187,000 (+17.76%) | Filing History |
| 2025-05-15 09:44 am Purchase | 2025-03-31 | 13G | ERASCA INC ERAS | Frazier Life Sciences Public Fund, L.P. | 22,575,851 8.000% | 6,359,635 (+39.22%) | Filing History |
| 2025-02-13 8:09 pm Sale | 2024-12-31 | 13G | ERASCA INC ERAS | Montanova Capital, LLC | 12,315,004 4.400% | -1,453,035 (-10.55%) | Filing History |
| 2025-02-12 5:02 pm Unchanged | 2024-12-31 | 13G | ERASCA INC ERAS | Novartis Pharma AG | 12,307,692 4.400% | 0 (Unchanged) | Filing History |
| 2024-11-14 5:13 pm Sale | 2024-05-21 | 13G | ERASCA INC ERAS | ARCH Venture Fund X L.P. | 0 0.000% | -11,055,554 (Position Closed) | Filing History |
| 2024-11-14 4:04 pm Sale | 2024-09-30 | 13G | ERASCA INC ERAS | Armistice Capital, LLC | 0 0.000% | -8,096,000 (Position Closed) | Filing History |
| 2024-11-14 1:28 pm Purchase | 2024-09-30 | 13G | ERASCA INC ERAS | T. Rowe Price Investment Management, Inc. | 16,830,856 6.000% | 16,830,856 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | ERASCA INC ERAS | BlackRock, Inc. BLK | 15,358,280 5.400% | 0 (Unchanged) | Filing History |